Company profile
Compass Therapeutics, Inc. insider acquisitions
Company CIK 0001738021 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 24, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| PurchaseCode P | Common StockNon-derivative · Currency not specified | 1 | 18,400 | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
17 dated transactions · 8 of 12 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | Compass Therapeutics, Inc.Common Stock | Lerner Neil | Purchase |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Shin Barry | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Common Stock | Shin Barry | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.STOCK OPTION (RIGHT TO BUY) | Sirard Cynthia | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Schuetz Thomas J. | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Common Stock | Schuetz Thomas J. | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.STOCK OPTION (RIGHT TO BUY) | Prasad Arjun | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | LINDAHL RICHARD S | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Chiniara Ellen | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Lerner Neil | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Common Stock | Lerner Neil | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | GRAY MARY ANN | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Boylan James P | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | GORDON CARL L | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Ferneau Philip | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Stock Option (Right to Buy) | Anderman Jonathan | Stock award |
| Jan 2, 2026 | Compass Therapeutics, Inc.Common Stock | Anderman Jonathan | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
CMPX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Lerner NeilChief Accounting Officer | PurchaseCommon StockNon-derivative security · Code P | 20,000 | 0.92Value: 18,400Currency not specified | View ↗ |
| Trade: | Shin BarryCFO | Stock awardStock Option (Right to Buy)Derivative security · Code A | 670,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Shin BarryCFO | Stock awardCommon StockNon-derivative security · Code A | 125,000 | 5.17Value: 646,250Currency not specified | View ↗ |
| Trade: | Sirard CynthiaChief Medical Officer | Stock awardSTOCK OPTION (RIGHT TO BUY)Derivative security · Code A | 1,000,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Schuetz Thomas J.CEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 2,000,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Schuetz Thomas J.CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 250,000 | 5.17Value: 1,292,500Currency not specified | View ↗ |
| Trade: | Prasad ArjunChief Commercial Officer | Stock awardSTOCK OPTION (RIGHT TO BUY)Derivative security · Code A | 1,000,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | LINDAHL RICHARD SDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Chiniara EllenDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Lerner NeilChief Accounting Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 435,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Lerner NeilChief Accounting Officer | Stock awardCommon StockNon-derivative security · Code A | 62,500 | 5.17Value: 323,125Currency not specified | View ↗ |
| Trade: | GRAY MARY ANNDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Boylan James PDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | GORDON CARL LDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Ferneau PhilipDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 90,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Anderman JonathanGeneral Counsel | Stock awardStock Option (Right to Buy)Derivative security · Code A | 720,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Anderman JonathanGeneral Counsel | Stock awardCommon StockNon-derivative security · Code A | 150,000 | 5.17Value: 775,500Currency not specified | View ↗ |
17 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →